Back

Development of TTRACK study diagnostic scores to identify elevated risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Assessment of prognosis in heart failure Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Cappelli

Careggi University Hospital (AOUC), Florence (Italy)

7 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Tawfek (Cardiff, GB)
Abstract Slides Video
Presentation thumbnail
Doctor T. Nishikawa (Toon, JP)
Abstract
Presentation thumbnail
Doctor B. Allen (Gainesville, US)
Abstract Slides Video
Presentation thumbnail
Ms M. Belkin (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Assessment of prognosis in heart failure

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Usefulness of a simple clinical score in identifying increased risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Comparative characteristics of patients with cardiac amyloidosis with and without monoclonal gammopathy in the TTRACK study population

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources